Cargando…
Novel Strategies to Improve the Endocrine Therapy of Breast Cancer
Endocrine therapy (ET) constitutes the usual first-line of therapy for patients in the treatment of metastatic hormone receptor-positive breast cancer. Unfortunately, not all patients respond to first-line endocrine treatment due to intrinsic resistance, while others may initially respond but eventu...
Autor principal: | Castrellon, Aurelio Bartolome |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444409/ https://www.ncbi.nlm.nih.gov/pubmed/28584571 http://dx.doi.org/10.4081/oncol.2017.323 |
Ejemplares similares
-
The Role of Carboplatin in the Neoadjuvant Chemotherapy Treatment of Triple Negative Breast Cancer
por: Castrellon, Aurelio Bartolome, et al.
Publicado: (2017) -
Current Strategies of Endocrine Therapy in Elderly Patients with Breast Cancer
por: Lee, Suk-young, et al.
Publicado: (2018) -
Status of adjuvant endocrine therapy for breast cancer
por: Schiavon, Gaia, et al.
Publicado: (2014) -
The immunomodulatory effects of endocrine therapy in breast cancer
por: Huang, Huanhuan, et al.
Publicado: (2021) -
Updates in endocrine therapy for metastatic breast cancer
por: Manohar, Poorni M., et al.
Publicado: (2022)